Michael Jarman

USPTO Granted Patents = 16 (Patent Applications = 2)

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 2

Average Co-Inventor Count = 3.4

ph-index = 6

Forward Citations = 165(Granted Patents)

Location History:

Tooting, GB (1996 - 1997)
Sutton, GB (1997 - 1999)
London, GB (1987 - 2015)

Company Filing History:

5 out of 61

Cancer Research Campaign Technology Limited

patents

4 out of 328

British Technology Group Limited

Cancer Research Technology Limited

patents

5. 2 out of 2

Secure Electrans Limited

patents

6. 2 out of 1,200

National Research Development Corporation

patents

where one patent can have more than one assignee

Years Active: 1987-2015

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9178895 - Data communication authentication system and method (2015-11-03),

2. 8846696 - Purine derivatives (2014-09-30),

3. 8725657 - Utility metering system incorporating a transaction authorisation system (2014-05-13),

4. 7582642 - Purine derivatives (2009-09-01),

5. 7544689 - Purine derivatives (2009-06-09),

6. 5977065 - Bacterial nitroreductase for the reduction of CB1954 and analogues (1999-11-02),

7. 5854244 - Melamine derivatives for use in the treatment of cancer (1998-12-29),

8. 5780585 - Bacterial nitroreductase for the reduction of CB 1954 and analogues (1998-07-14),

9. 5716990 - Drug delivery systems (1998-02-10),

10. 5633158 - Bacterial nitroreductase for the reduction of CB 1954 and analogues (1997-05-27),

11. 5618807 - Method for preparing 17-substituted steroids useful in cancer treatment (1997-04-08),

12. 5604213 - 17-substituted steroids useful in cancer treatment (1997-02-18),

13. 5595995 - Pyridyl-propan-2-yl esters of 1-adamantane carboxylates (1997-01-21),

14. 5589500 - Substituted 1,1,2-triphenylbutenes and their use in the treatment of (1996-12-31),

15. 5071857 - 2,6-dioxopiperidine derivatives, their preparation and pharmaceutical (1991-12-10),

Title: Michael Jarman: Innovator in Data Communication and Pharmaceutical Compounds

Introduction

Michael Jarman is a notable inventor based in London, GB. He has made significant contributions to the fields of data communication and pharmaceuticals, holding a total of 16 patents. His innovative work has paved the way for advancements in technology and medicine.

Latest Patents

Among his latest patents is a data communication authentication system and method. This system involves the installation of one or more locator nodes at a specific location, each equipped with an identifier and a communication system. The system generates an authentication code based on the identifiers from these locator nodes, providing the code on demand for data communication originating locally. Another significant patent relates to purine derivatives, which encompasses compounds that have potential applications in treating various disorders, including proliferative and viral disorders, stroke, alopecia, CNS disorders, neurodegenerative disorders, and diabetes.

Career Highlights

Michael Jarman has worked with prominent organizations such as Cancer Research Campaign Technology Limited and British Technology Group Limited. His experience in these companies has contributed to his expertise and innovative capabilities in his fields of interest.

Collaborations

Throughout his career, Jarman has collaborated with notable individuals, including Gerard A Potter and Ian R Hardcastle. These collaborations have likely enriched his work and led to further advancements in his projects.

Conclusion

Michael Jarman's contributions to data communication and pharmaceuticals highlight his role as a significant inventor. His patents reflect a commitment to innovation and the advancement of technology and medicine.

This text is generated by artificial intelligence and may not be accurate.